Skip to content

Ultrasound Guided Steroids Injection Versus PRP for Shoulder Pain Relief

Evaluation of Ultrasound Guided Platelet Rich Plasma Injection Versus Steroids Injection for Pain Relief in Cases of Partial Rotator Cuff Tears

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05317624
Acronym
PRP
Enrollment
60
Registered
2022-04-08
Start date
2021-08-10
Completion date
2023-02-01
Last updated
2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain

Brief summary

Comparison between effects of ultrasound guided platelet rich plasma injection versus steroids injection for pain relief in cases of partial rotator cuff tears

Detailed description

The effect of injection of platelet rich plasma will be compared with effects of steroids injection according to pain relief effects,, Side effects ,, healing ability ,, recurrence in both groups. 30 patient in each group will be included

Interventions

COMBINATION_PRODUCTPlatelet rich plasma

platelet rich plasma will be obtained from the particepants own blood mixed with activator and bupivacaine

COMBINATION_PRODUCTMethylprednisolone

1ml methyl prednisolone 40mg\\ml mixed with normal saline and bupivacaine

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

2 groups will be included

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients with positive tests for rotator cuff pain 2. Patients with positive radiological (US or MRI) findings of partial rotator cuff tear

Exclusion criteria

1. Patient refusal 2. Age less than 20 years. 3. Infection at injection site. 4. Prior surgery on the shoulder joint area. 5. Presence of other associated pathology in the shoulder joint 6. Patients using antiplatelet drugs (aspirin). 7. Contraindications to the use of platelet concentrate 8. Contraindications to the steroids injection

Design outcomes

Primary

MeasureTime frameDescription
Shoulder pain assesment4 monthsThe pain will be assessed using visual analogue scale( score range=0-10,less than 4,4-6 and more than 6 for mild, moderate and severe pain respectively)

Secondary

MeasureTime frameDescription
Assesment the failure rate after shoulder joint injection4 monthsfailure of relief the symptoms after shoulder joint injection will be recorded
Assesment of rotator cuff tendon healing4 monthsassesment healing process of tendon using ultrasound technique
The reinjection rate recording4 monthsthe incidence of reinjection the shoulder joint due to inadequate pain relief will be recorded
Assesment the rate of tear recurrence after shoulder joint injection4 monthsThe rate of tear recurrence after 4 months of injection will be assessed using MRI or US
Simple shoulder assessment test4 monthsFunctional assessment of shoulder joint will be done using simple sholder assessment test 0= maximal disability 20% -40% = crippled 40% -60% = severe disability 60% -80% = moderate disability 100% = no disability

Other

MeasureTime frameDescription
Assesment the complications after shoulder joint injection4 monthsComplications that might occur after shoulder joint injection such as infection, elevated blood sugar, allergy, nerve injury, nausea and vomiting will be recorded
Measurement the serum cortisol levelone weekEarly morning(8 am serum cortisol level) will be measured before the injection and one week later after injection
Measurement the fasting blood glucose levelone weekThe fasting blood glucose level will be measure prior to and one week later after injection
Measurement plasma C-Reactive Protein level4 monthsThe plasma C- Reactive Protein level will be measured prior to injection and 4 months later on after the procedure

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026